- •
COPD is characterized by heterogeneous physiologic abnormalities that are not adequately represented by simple spirometry.
- •
Extensive peripheral airway dysfunction is often present in smokers with mild spirometric abnormalities and may have negative clinical consequences.
- •
Activity-related dyspnea and exercise intolerance in patients with mild airway obstruction are linked to increased ventilatory inefficiency and dynamic gas trapping during exercise.
- •
Progressive increases in dyspnea and activity
Chronic Obstructive Pulmonary Disease: Clinical Integrative Physiology
Section snippets
Key points
Clinical Relevance
It is well established that those with mild-to-moderate disease severity represent most patients with COPD, yet this subpopulation is understudied.1, 2 For the purpose of this review, mild COPD refers to spirometrically defined mild airway obstruction (ie, FEV1 80%–100 % predicted), which need not be synonymous with early COPD. There is evidence from several population studies that, compared with nonsmoking healthy populations, smokers with mild COPD show increased mortality (including
Moderate-to-severe COPD
Concepts of the natural history of COPD are strongly influenced by the seminal longitudinal population study of Fletcher and Peto80 who have charted the decline in FEV1 with time in susceptible smokers. Much less information is available on the temporal evolution of complex mechanical abnormalities and of pulmonary gas exchange abnormalities. Clearly, disease progression is characterized by worsening of the heterogeneous physiologic derangements already outlined in mild COPD. Recent short-term
Physiologic mechanisms of dyspnea in COPD
Most patients with COPD experience dyspnea during daily activities.117, 124, 167 As COPD progresses, dyspnea intensity ratings become progressively higher at any given V′E, power output, or metabolic load (Fig. 8).108 At the breakpoint of exercise healthy individuals report that their breathing requires more work or effort.104 However, patients with COPD additionally report the sense of unsatisfied inspiration (“can’t get enough air in”).97, 104, 110 These distinct qualitative dimensions of
Summary
COPD is characterized by diverse physiologic derangements that are not adequately represented by simple spirometry. The human respiratory system has enormous reserve and develops effective compensatory strategies to fulfill its primary function of maintaining blood gas homeostasis even in the face of extensive injury to the small airways, lung parenchyma, and its microvasculature. These physiologic adaptations together with behavioral modification (eg, activity avoidance) can result in a
References (171)
- et al.
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
Lancet
(1997) - et al.
International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study
Lancet
(2007) - et al.
COPD as a multicomponent disease: inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care
Prim Care Respir J
(2006) - et al.
Sex differences in exertional dyspnea in patients with mild COPD: physiological mechanisms
Respir Physiol Neurobiol
(2011) - et al.
Six-minute walk distance predictors, including CT scan measures, in the COPDGene cohort
Chest
(2012) - et al.
Quantitative CT measurement of cross-sectional area of small pulmonary vessel in COPD: correlations with emphysema and airflow limitation
Acad Radiol
(2010) - et al.
Respiratory system impedance with impulse oscillometry in healthy and COPD subjects: ECLIPSE baseline results
Respir Med
(2011) - et al.
Pulmonary mechanics. A unified analysis of the relationship between pressure, volume and gasflow in the lungs of normal and diseased human subjects
Am J Med
(1960) - et al.
Chronic obstructive pulmonary disease early intervention trial (lung health study). Baseline characteristics of randomized participants
Chest
(1993) - et al.
Early changes of cardiac structure and function in COPD patients with mild hypoxemia
Chest
(2005)
Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study
Respir Med
Sub-clinical left and right ventricular dysfunction in patients with COPD
Respir Med
Percent emphysema and right ventricular structure and function: the MESA Lung and MESA-RV Studies
Chest
The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature
Chest
CT and physiologic determinants of dyspnea and exercise capacity during the six-minute walk test in mild COPD
Respir Med
Effects of BMI on static lung volumes in patients with airway obstruction
Chest
Physical activity and hospitalization for exacerbation of COPD
Chest
Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease
Respir Med
Low inspiratory capacity to total lung capacity ratio is a risk factor for chronic obstructive pulmonary disease exacerbation
Am J Med Sci
Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes
Chest
Effect of adjunct fluticasone propionate on airway physiology during rest and exercise in COPD
Respir Med
Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study
Thorax
Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population
Am J Respir Crit Care Med
Early detection and impaired quality of life in COPD GOLD stage 0: a pilot study
COPD
Do GOLD stages of COPD severity really correspond to differences in health status?
Eur Respir J
Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group
Ann Intern Med
Health status measurement in chronic obstructive pulmonary disease
Thorax
Development and first validation of the COPD assessment test
Eur Respir J
COPD as a lung disease with systemic consequences: clinical impact, mechanisms, and potential for early intervention
COPD
Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study
Am J Respir Crit Care Med
Characteristics of physical activities in daily life in chronic obstructive pulmonary disease
Am J Respir Crit Care Med
Lower limb activity and its determinants in COPD
Thorax
Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease
Am J Respir Crit Care Med
Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD
Thorax
Does the respiratory system limit exercise in mild COPD?
Am J Respir Crit Care Med
Lung hyperinflation and its reversibility in patients with airway obstruction of varying severity
COPD
Prediction of the rate of decline in FEV(1) in smokers using quantitative computed tomography
Thorax
Site and nature of airway obstruction in chronic obstructive lung disease
N Engl J Med
The nature of small-airway obstruction in chronic obstructive pulmonary disease
N Engl J Med
Small-airway obstruction and emphysema in chronic obstructive pulmonary disease
N Engl J Med
Emphysema: a disease of small airways or lung parenchyma?
N Engl J Med
Mechanism of expiratory airflow limitation in chronic obstructive pulmonary disease associated with 1-antitrypsin deficiency
Am Rev Respir Dis
Contributions of loss of lung recoil and of enhanced airways collapsibility to the airflow obstruction of chronic bronchitis and emphysema
J Clin Invest
A four-year follow-up study of lung mechanics in smokers
Am Rev Respir Dis
Frequency dependence of compliance as a test for obstruction in the small airways
J Clin Invest
Does the single-breath N2 test identify the smoker who will develop chronic airflow limitation?
Am Rev Respir Dis
Volume of isoflow. A new test in detection of mild abnormalities of lung mechanics
Am Rev Respir Dis
The use of a helium-oxygen mixture during maximum expiratory flow to demonstrate obstruction in small airways in smokers
J Clin Invest
Effects of smoking on changes in respiratory resistance with increasing age
Clin Sci (Lond)
Physiologic diagnosis of subclinical emphysema
Am Rev Respir Dis
Cited by (107)
Dynamic hyperinflation is a risk factor for mortality and severe exacerbations in COPD patients
2024, Respiratory MedicineExertional dyspnea responses to the Dyspnea Challenge in heart failure: Comparison to chronic obstructive pulmonary disease
2023, Heart and LungCitation Excerpt :The results reported here support these notions in that those with COPD exercised at a higher V̇E/MVV (i.e. lower breathing reserve), and dynamically hyperinflated by approximately 400 ml – twice the amount of those with HF. In COPD, dynamic hyperinflation causes weakness in respiratory muscles, increases ventilation-perfusion mismatching, decreases SpO2, and increases reliance on anaerobic metabolism.34,37,38 Our recruited sample size for HF and COPD was small, and further study is warranted to confirm these findings in a larger sample with a greater variety of disease severities.
Exertional Dyspnoea responses reported in the Dyspnoea Challenge and measures of disease severity in COPD
2022, Respiratory Physiology and NeurobiologyLung Function Testing in Chronic Obstructive Pulmonary Disease
2020, Clinics in Chest MedicineHaemodynamic compensations for exercise tissue oxygenation in early stages of COPD: an integrated cardiorespiratory assessment study
2024, BMJ Open Respiratory Research